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Reply to the Editor: 
My colleagues and I are pleased with the endorsement 
of the video-assisted thoracoscopic (VAT) technique for 
thymectomy by Mineo, Pompeo, and Ambrogi. It is 
heartening to see preliminary confirmation of the safety 
and efficacy of the technique in another institution. 
Regarding the issues raised in their letter, we also began 
the VAT approach for thymectomy from the left side 
because preoperative computed tomographic assessment 
indicated that the thymus gland was usually more promi- 
nent and larger on the left side. As a result of the 
experience of one of our colleagues (Anthony Yim), we 
gradually adopted the right-sided approach. Although it is 
a matter of surgical preference, we routinely have found 
the right-sided approach technically easier than the left- 
sided approach for a number of reasons. 
1. From the left side, the recess medial to the superior 
vena cava and inferior to the innominate vein was the 
most difficult area to visualize and dissect. This portion of 
the procedure is more easily accomplished from the right 
side. 
2. Identification of the innominate vein from the left 
side occasionally presented some difficulties. Initial iden- 
tification of the superior vena cava from the right side 
allows easy identification of and dissection along the 
innominate vein from the right side. 
3. For right-handed surgeons, performing a VAT oper- 
ation beginning inferiorly and working cephalad is ergo- 
nomically simpler from the right side of the patient han 
from the left side. 
4. A neck dissection is equally easy to accomplish from 
either side. 
In the final analysis, however, we believe that the 
surgeon's preference should rule--whichever side he or 
she feels most comfortable on is the one that should be 
used. Although we rarely use carbon dioxide insuffiation 
for most VAT procedures, we do think that VAT thymec- 
tomy is an instance in which the adjuvant pneumomedi- 
astinum facilitates visualization and dissection, especially 
when crossing to the opposite side and performing the 
dissection in the aortopulmonary window. It also facili- 
tates identification and dissection of the superior horns of 
the gland in the cervical area. As mentioned in the 
manuscript and by Mineo, Pompeo, and Ambrogi, we 
totally agree that removal of all anterior mediastinal tissue 
is necessary to assure a complete thymectomy. 
We congratulate Mineo, Pompeo, and Ambrogi on 
their experience with 12 cases. We believe that the 
technique, whether performed by the right- or left-sided 
approach, needs to be evaluated by longer follow-up in 
larger series first. We further believe that a multiinstitu- 
tional study to determine which side is more appropriate 
is a lesser issue that should be studied after efficacy of the 
procedure has been definitively proved by long-term fol- 
low-up. In the 14 months ince completion of our reported 
study, our results, although still intermediate, continue the 
early trends. 
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Treatment of heparin-induced thrombocytopenia 
To the Editor." 
In the November 1996 issue of the Journal (1996;112: 
1390-92), Ganjoo, Harloff, and Johnson reported the case 
of a patient with heparin-induced thrombocytopenia 
(HIT) treated by enoxaparin. They concluded that cardiac 
operations can be safely done with the use of a circuit 
coated with Carmeda Bioactive Surface (Medtronic, Ana- 
heim, Calif.) in combination with low-molecular-weight 
heparin in patients with HIT. I would like to comment on 
this conclusion. 
If thrombocytopenia develops as a result of heparin, the 
heparin infusion should be stopped immediately. It is, 
however, difficult to choose an alternative anticoagulant. 
Initial reports have described the use of low-molecular- 
weight heparin instead of unfractionated heparin. 1 Re- 
cently Warkentin, 2 Peters, 3Magnani. 4and their associates 
emphasized that low-molecular-weight heparin is not in- 
dicated for the treatment of patients with HIT because of 
extensive cross-reactivity (80% to 90%). Patients with 
HIT who were treated by the heparinoid danaparoid 
sodium (ORG 10172; Orgaran) had lower cross-reactivity 
(10%). However, before the heparin0id anaparoid so- 
dium (ORG 10172) or eventually low-molecular-weight 
heparin is substituted for heparin, the plasma of the 
patients hould be tested for cross-reactivity oward one 
or more of these agents (platelet aggregation or 14- 
seratonin release test). The alternative anticoagulant is 
safer if no cross-reactivity has been detected. If acute 
replacement of heparin is necessary, the best option is 
danaparoid sodium (ORG 10172). Other approaches to 
the treatment are not conclusive. 
F. P. J. Peters, MD 
University Hospital Maastricht 
Department of Internal Medicine 
Division of Haematology and Oncology 
Postbus 5800 
6202 AZ Maastricht, The Netherlands 
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